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We report the synthesis of a bipyridyl reagent containing a strained alkyne, which signiﬁcantly restricts its
ﬂexibility. Upon strain-promoted alkyne-azide cycloaddition (SPAAC) with an azide, which does not
require a Cu catalyst, the structure becomes signiﬁcantly more ﬂexible and an increase in ﬂuorescence is
observed. Upon addition of Zn(II), the ﬂuorescence is enhanced further. The reagent has the potential to
act as a ﬂuorescent labelling agent with azide-containing substrates, including biological molecules.Introduction
Zinc is a vital trace element and is required in the basic cellular
function of many biological organisms.1 In humans, proteins
that bind zinc account for ca. 10% of all proteins,2 and zinc is
the only transition metal found across all classes of enzymes.3 It
is essential for important processes such as gene expression,4
neurotransmission,5 regulation of apoptosis6 and in reproduc-
tion.7 Maintenance of the correct intracellular levels of zinc is
clearly requisite for critical cell functions. Indeed, mis-
regulation of zinc in the brain is implicated in a range of
neurological disorders such as epilepsy and Alzheimer's
disease.4 Abnormal zinc levels are also intrinsically linked to
cancer and are an important factor in apoptosis of malignant
tumours.8 These factors have driven research into treatments or
diagnostic tools for Zn(II), through the design of complexation
agents and sensors. Molecules which modulate their uores-
cence upon undergoing a reaction have the potential to selec-
tively indicate the location of specic functional groups or
analyte, for example azide- or alkyne-containing proteins or
other synthetic molecules.9 Azido coumarin 1 is an example of
a reagent which increases signicantly in uorescence upon
cycloaddition with an alkyne.9a In cases where the partner is
a strained alkyne,10 the cycloaddition reaction can take place
without the need for a copper catalyst,11 which is highly
advantageous in a biological setting due to its bioorthogonality
(Scheme 1).11
We, and others, have recently reported the synthesis and
reactions of a strained alkyne of general structure 2, derived
from a biphenol backbone (Fig. 1).12 Although not asWarwick, Coventry, CV4 7AL, UK. E-mail:
eutical Sciences, IMED Biotech Unit,
SI) available: Experimental procedures,
0.1039/c9ra06866j
1reactive as the more strained commercial reagents such as
3–5,10,11 it is simple to prepare via a short sequence, reacts
with azides without a metal catalyst and has been demon-
strated to be capable of forming synthetically-useful deriv-
atives. We have also reported a dialkyne version of this
reagent, i.e. 6.12d
Although strained alkynes such as 3–5 can be functionalised
with a uorescent group,13 we felt that it would be advantageous
to design a reagent which could potentially gain uorescence
upon undergoing the cycloaddition reaction. Toward this end
we designed reagent 7, which contains a bipyridyl functional
group, reasoning that its out-of-plane locking of the aryl rings by
the inexible alkyne would prevent uorescence and eliminate
the potential for metal chelation between the pyridiyl nitrogen
atoms. However, upon cycloaddition with an azide, the rotation
barrier about the biaryl C–C bond should be decreased,
increasing the propensity to become co-planar and thus become
weakly emissive, which has the potential to increase further
upon chelation of a suitable metal ion such as Zn(II), which are
known to be highly emissive.14 Related reagents based on the
same dipyridyl scaﬀold have been reported,15 providing some
precedent for our synthetic approach.Results and discussion
The target reagent, 7, was prepared through a two-step process
by rst forming the known 2,20-bipyridyl-3,30-diol 8 16 from
iodopyridine 9 using a new protocol, and then cyclising the
reagent through reaction with but-2-yne-1,4-diyl bis(4-
methylbenzenesulfonate), following our established protocol,
to give 7 in 41% yield. The 1H NMR spectrum of 7 exhibited
diastereotopic CH2 resonances indicating conversion between
atropisomers is slow on the NMR timescale (500 MHz, CDCl3,
298 K). Correspondingly, it was found that compound 7 was not
an eﬀective bidentate ligand, likely due to the large C–C biaryl
torsional angle; our previous solid-state studies of biphenolThis journal is © The Royal Society of Chemistry 2019
Scheme 1 Uncatalysed reaction of azide with strained cyclooctyne, and a coumarin reagent which ﬂuoresces upon undergoing a cycloaddition.
Fig. 1 Reported strained alkynes.
Scheme 2 Synthesis of 2,2-bipyridyl strained alkyne 7.
Paper RSC Advancesstrained alkynes evidence signicantly non-planar C–C biaryl
bond dihedral angles (Scheme 2).12a
The cycloaddition of 7 with benzylazide was studied (Scheme
3), using 1H-NMR to follow the changes in situ. The reactionScheme 3 Cycloaddition of bipyridyl strained alkyne 7with benzyl azide.
on the rate.
This journal is © The Royal Society of Chemistry 2019took place without the requirement for a copper catalyst,
generating the cycloadduct 10 in high yield over several days.
The adduct 10 was qualitatively more uorescent than the 2,20-
bipyridyl strained alkyne 7, presumably due to the reducedThe reaction was run with and without ZnCl2 in order to gauge its eﬀect
RSC Adv., 2019, 9, 36154–36161 | 36155
Fig. 2 Overlaid 1H NMR spectra (400 MHz, CD3CN, 298 K) for the cycloaddition reaction in Scheme 3 without added ZnCl2.
RSC Advances Paperrotational restriction upon cycloaddition. The cycloaddition in
the presence of ZnCl2 was slightly faster than in its absence and
gave a signicantly emissive adduct. It is unclear as to how the36156 | RSC Adv., 2019, 9, 36154–36161Zn(II) accelerates the reaction however it is unlikely to chelate to
the two pyridyl rings due to the likely wide torsion angle in the
strained alkyne (vide supra).This journal is © The Royal Society of Chemistry 2019
Fig. 3 Overlaid 1H NMR spectra (400 MHz, CD3CN, 298 K) for the cycloaddition reaction in Scheme 3 with added ZnCl2.
Paper RSC AdvancesThe NMR spectra, recorded at time intervals, of the cyclo-
addition without ZnCl2 are overlaid in Fig. 2; the product CH2
resonances are broad, indicating that the detected hydrogenThis journal is © The Royal Society of Chemistry 2019atoms are alternating between diﬀerent conformations due to
restricted rotations on the NMR time scale, as previously
observed for cycloadducts of this type.12 A variable temperatureRSC Adv., 2019, 9, 36154–36161 | 36157
Fig. 4 1H NMR spectrum (400 MHz, CD3CN, 298 K) for the uncomplexed addition product 10 after adding ZnCl2.
RSC Advances Paper1H NMR study of 10 (500 MHz, CDCl3) revealed that the slow
exchange of the atropisomers is reached at 243 K, contrasting 7
which is resolved at ambient temperature, indicating greater
exibility of 10, however coalescence was not reached at 323 K
(ESI†).
The NMR spectra recorded, at each time interval, of the
ZnCl2-complexed cycloaddition reaction are similarly overlaid
in Fig. 3. In this case the product peaks were sharp, with three
singlets being formed, corresponding to each of the CH2 groups
in the product. In an independent test, ZnCl2 (1.0 eq., CD3CN)
was added to the uncomplexed NMR sample, resulting in sharp
NMR peaks similar to the Zn(II)-complexed product 10 (Fig. 4).
It is unclear why the compound which had Zn(II) added
before the cycloaddition reaction has three singlet peaks that
each integrate to two hydrogens, while the compound which
had Zn(II) added aer the cycloaddition reaction has two singlet
peaks, one of which integrates to four hydrogens and the other
which integrates to two hydrogens. Since Zn(II) is able to formFig. 5 Structures of uncomplexed and Zn(II)-complexed bipyridyl cycloa
36158 | RSC Adv., 2019, 9, 36154–36161complexes with up to three bipyridyl compounds, this could be
due to a diﬀerent ratio of Zn(II) to bipyridyl in each sample.14
The observations indicate that the Zn(II) complexation is likely
to be responsible for the change in appearance of the NMR
spectrum, possibly due to the attening of the ring and reduc-
tion of the degrees of freedom (Fig. 5).
Whilst this Zn(II) complexation with a bipyridyl strained
alkyne cycloaddition adduct is novel, Zn(II) complexation with
bipyridyl compounds, to create highly uorescent adducts, has
been previously studied in detail.14 Zn(II) complexation has been
shown to increase uorescence intensity, a property which
could potentially be benecial for uorescence-based reagents.
The eﬀect of Zn(II) complexation on uorescence was also
observed on both the cycloaddition bipyridyl product 10 and the
precursor bipyridyl diol 8. All samples were made to the same
concentration (105 M), and values were recorded at the same
parameters on the same instrument (Fig. 6). The strained alkyne
reagent 7 was also studied for comparison purposes.ddition product 10.
This journal is © The Royal Society of Chemistry 2019
Fig. 6 (a) Emission spectra of 10 without and with added ZnCl2, with
excitation at 340 nm, and (b) 3D excitation vs. emission spectrum of
10/ZnCl2. The 3D spectrum of uncomplexed 10 is given in the ESI.†
Fig. 7 Comparison of emission of complexes of 10 with a range of
metals at 340 nm excitation; 3D and contour excitation vs. emission
spectra are given in the ESI.†
Table 1 Intensities at the maximum excitation and emission wave-
lengths for metal complexes of 10a
Excitation lmax
(nm)
Emission
lmax (nm) Intensity
Shi/
nm
Uncomplexed 10 295 379 23 85
10 Zn II complex 341 400 279 59
10 Cu I complex 340 439 7 99
10 Cu II complex 345 438 5 93
10 Co II complex 325 450 6 75
10 Fe II complex 335 450 8 115
a Spectra were recorded at a concentration of 105 M in MeCN.
Paper RSC AdvancesBased on relative intensity, cycloaddition product 10 showed
a signicant increase in uorescence upon addition of ZnCl2
(Fig. 6) In contrast, addition of Zn(II) to the solution of 7 resulted
in quenching of the uorescence (ESI†). This indicated that
chelation of the metal was required for increased uorescence,
since the rigid structure of 7 prevents this. Aer observing the
increase in uorescence with Zn(II) for cycloaddition bipyridyl
product 10, it was complexed with several other metal salts to
investigate the selectivity of the system. The 3D uorescence
spectra were recorded for each of the metal complexes (SchemeScheme 4 Metal complexation with bipyridyl product 10.
This journal is © The Royal Society of Chemistry 20194, Fig. 7) The 3D and contour excitation vs. emission spectra are
given in the ESI†.
The Zn(II)-complexed bipyridyl 10 exhibited a signicantly
higher uorescence intensity compared to the other metal
complexes; none of the other metals enhanced the uorescence
of the bipyridyl 10; moreover, the other metal complexes had
lower emission intensities than even the uncomplexed bipyridyl
7. Table 1 summarises the combination of excitation and
emission wavelength that gave the highest response as deter-
mined by 3D uorescence spectroscopy, and the Stokes shis.
For comparison, the uorescence of the ZnCl2-complexed and
uncomplexed bipyridyl diol precursor 8 17 was also measured
using 3D uorescence spectroscopy (Fig. 8).RSC Adv., 2019, 9, 36154–36161 | 36159
Fig. 8 Fluorescence spectra for diol 8 (a) without added ZnCl2 (b) with added ZnCl2. (c) Contrasting emissions at 405 and 360 nm excitation with
and without added Zn(II).
RSC Advances PaperOnce again, the Zn(II) complexation caused a dramatic
increase in the uorescent intensity of the compound, although
the selection of excitation wavelength was crucial in establishing
the sharpest diﬀerence between the complexed and uncom-
plexed emission. With excitation at 405 nm, sharply contrasting
emission results were obtained compared to those at 360 nm
excitation, where little diﬀerence was observed (Fig. 8c). The high
uorescence reects eﬃcient chelation of the Zn(II) by diol 8.
Conclusion
In conclusion, we have prepared a new strained alkyne based on
a bipyridyl dioxy backbone and have applied this to strain-
promoted cycloaddition reactions with benzyl azide. Metal
complexation is precluded on the alkyne compound 7 due to the
rigidity and non-coplanarity of the bipyridine. Upon triazole
formation, product 10 increases in conformational exibility,
allowing coordination to a range of transition and alkaline earth
metals, as evidence by photophysical studies. Importantly, the
uorescence intensity increases signicantly when Zn(II) salts
are added to it, which is selective across the ranges of metals
studied.
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